FHI works with partners to undertake research into new contraceptive methods


Contraceptive implants, which were introduced more than 25 years ago, are one of the most effective family planning methods developed to date. Even though they have potential to reduce the number of unwanted pregnancies significantly, they are underutilized, primarily because of their high cost. Few programs and clinics are able to offer the method and stockouts are frequent.

To address these problems, FHI is facilitating the introduction of Sino-implant (II) -- a long-acting, safe, and affordable contraceptive implant. Sino-implant (II) costs about 70 percent less than implants currently on the market: Norplant, Jadelle, and Implanon. As a result, it can be offered to women on a much broader scale than the other implants and reduce the high unmet need for contraception.